Skip to main content
. 2016 Feb 12;6:20913. doi: 10.1038/srep20913

Figure 1. Patient enrollment flow chart.

Figure 1

NSCLC, non-small cell lung cancer; EGFR-TKI, epidermal growth factor receptor-tyrosine kinase inhibitor; PD, progressive disease.